@article{8ae974d4963a4ea3b85df7b783585835,
title = "Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study",
author = "{D:A:D study group, the Royal Free Hospital Clinic Cohort, and the INSIGHT, SMART, and ESPRIT study groups} and Amanda Mocroft and Lundgren, {Jens D.} and Michael Ross and Matthew Law and Peter Reiss and Ole Kirk and Colette Smith and Deborah Wentworth and Jacqueline Neuhaus and Fux, {Christoph A.} and Olivier Moranne and Phillipe Morlat and Johnson, {Margaret A.} and Lene Ryom and B. Powderly and N. Shortman and C. Moecklinghoff and G. Reilly and X. Franquet and Sabin, {C. A.} and A. Phillips and R. Weber and C. Pradier and {d'Arminio Monforte}, A. and F. Dabis and El-Sadr, {W. M.} and {De Wit}, S. and D. Kamara and J. Tverland and M. Mansfeld and J. Nielsen and D. Raben and {Salb{\o}l Brandt}, R. and M. Rickenbach and I. Fanti and E. Krum and M. Hillebregt and S. Geffard and A. Sundstr{\"o}m and M. Delforge and E. Fontas and F. Torres and H. McManus and S. Wright and J. Kj{\ae}r and A. Sj{\o}l and P. Meidahl and J. Helweg-Larsen and {Schmidt Iversen}, J. and B. Johnston",
note = "Funding Information: PM: honoraria or travel/meeting expenses from Bristol-Myers Squibb, Gilead, Janssen-Cilag, Merck Sharp & Dohme-Chibret and ViiV Healthcare in the past five years. ML received unrestricted grants to my institution from Boehringer Ingelhiem, Gilead Sciences, Merck Sharp & Dohme, Bristol-Myers Squibb, Janssen-Cilag, ViiV HealthCare. CS has received funds for preparation of Educational Materials from Janssen, Gilead, BMS, ViiV HealthCare, support for attendance at Ad board and support to attend HIV conference from Gilead, funding to conduct study from BMS. OM has received honoraria as a speaker from Abbott and Gilead Sciences, serves on the board of Roche, and had expenses paid by Roche and Baxter for travel, accommodations, and meetings. OK has received honoraria, consultancy, lecture fees, and travel grants from Abbott Laboratories, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck Sharp & Dohme, Roche, and ViiV Healthcare, and has served/is serving on Advisory Boards for Gilead Sciences, Merck Sharp & Dohme, and ViiV Healthcare. AM has received honoraria, consultancy, lecture fees, and travel grants from Gilead Sciences, Merck Sharp & Dohme, Boehringer Ingelheim, Pfizer and GSK. Publisher Copyright: {\textcopyright} 2015 Mocroft et al.",
year = "2015",
month = mar,
day = "1",
doi = "10.1371/journal.pmed.1001809",
language = "English",
volume = "12",
journal = "PLoS Medicine",
issn = "1549-1277",
number = "3",
}
